| Authors: |
Fowler JC; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge, UK., Sood RK; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge, UK., Coltart G; Dermatopharmacology, University of Southampton, Southampton General Hospital, Southampton, UK.; Dermatology, University Hospital Southampton NHS Foundation Trust, Southampton, UK., Lai C; Dermatopharmacology, University of Southampton, Southampton General Hospital, Southampton, UK.; Dermatology, University Hospital Southampton NHS Foundation Trust, Southampton, UK.; Department of Medicine and Therapeutics, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong SAR, China., Nadarajah N; Dermatopharmacology, University of Southampton, Southampton General Hospital, Southampton, UK., Holloway JW; Human Development and Health, University of Southampton, Southampton General Hospital, Southampton, UK.; Institute for Life Sciences, University of Southampton, Southampton, UK., Rose-Zerilli MJJ; Institute for Life Sciences, University of Southampton, Southampton, UK.; Cancer Sciences, University of Southampton, Southampton General Hospital, Southampton, UK., Diffey B; Translational and Clinical Research Institute (Dermatology), Newcastle University, Newcastle upon Tyne, UK., Jones PH; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge, UK.; Department of Oncology, University of Cambridge, Hutchison Research Centre, Cambridge, UK., Healy E; Dermatopharmacology, University of Southampton, Southampton General Hospital, Southampton, UK.; Dermatology, University Hospital Southampton NHS Foundation Trust, Southampton, UK. |
